ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 754245 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 754245; 2) Community: the network communities that were significantly associated with the response to NSC 754245; 3) Molecule: the relationships between components within communities and NSC 754245; 4) MDR: the compounds that were significantly associated with the NSC 754245.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0108954273764103 0.16506742
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0108954273764103 0.037477728
NSC 735030 Null 0.0108954273764103 0.054556306
NSC 740 Methotrexate 0.0108954273764103 0.43612525
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.0108954273764103 0.24435576
NSC 743528 Null 0.0108954273764103 0.33132116
NSC 746540 Null 0.0108954273764103 0.1611891
NSC 113452 Null 0.0138010872611484 0.33464127
NSC 119621 Null 0.0138010872611484 0.10193236
NSC 143241 Dibenzo[de,g]quinoline-6-carboxylic acid, 4,5-dihydro- 1,2,9,10-tetramethoxy-, ethyl ester 0.0138010872611484 0.17589541
Total:133  Current:54    [First] [Prev] [Next] [Last]